Literature DB >> 16440002

RNA editing and alternative splicing: the importance of co-transcriptional coordination.

Jurga Laurencikiene1, Annika M Källman, Nova Fong, David L Bentley, Marie Ohman.   

Abstract

The carboxy-terminal domain (CTD) of the large subunit of RNA polymerase II (pol II) is essential for several co-transcriptional pre-messenger RNA processing events, including capping, 3'-end processing and splicing. We investigated the role of the CTD of RNA pol II in the coordination of A to I editing and splicing of the ADAR2 (ADAR: adenosine deaminases that act on RNA) pre-mRNA. The auto-editing of Adar2 intron 4 by the ADAR2 adenosine deaminase is tightly coupled to splicing, as the modification of the dinucleotide AA to AI creates a new 3' splice site. Unlike other introns, the CTD is not required for efficient splicing of intron 4 at either the normal 3' splice site or the alternative site created by editing. However, the CTD is required for efficient co-transcriptional auto-editing of ADAR2 intron 4. Our results implicate the CTD in site-selective RNA editing by ADAR2 and in coordination of editing with alternative splicing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440002      PMCID: PMC1456888          DOI: 10.1038/sj.embor.7400621

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  34 in total

1.  Structure and sequence determinants required for the RNA editing of ADAR2 substrates.

Authors:  T Renee Dawson; Christopher L Sansam; Ronald B Emeson
Journal:  J Biol Chem       Date:  2003-11-30       Impact factor: 5.157

Review 2.  The link between mRNA processing and transcription: communication works both ways.

Authors:  Diego A R Zorio; David L Bentley
Journal:  Exp Cell Res       Date:  2004-05-15       Impact factor: 3.905

Review 3.  Multiple links between transcription and splicing.

Authors:  Alberto R Kornblihtt; Manuel de la Mata; Juan Pablo Fededa; Manuel J Munoz; Guadalupe Nogues
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

4.  Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3'-end cleavage.

Authors:  Emanuel Rosonina; Benjamin J Blencowe
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

5.  RNA editing in brain controls a determinant of ion flow in glutamate-gated channels.

Authors:  B Sommer; M Köhler; R Sprengel; P H Seeburg
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

6.  RNA polymerase II C-terminal domain required for enhancer-driven transcription.

Authors:  H P Gerber; M Hagmann; K Seipel; O Georgiev; M A West; Y Litingtung; W Schaffner; J L Corden
Journal:  Nature       Date:  1995-04-13       Impact factor: 49.962

7.  Control of kinetic properties of AMPA receptor channels by nuclear RNA editing.

Authors:  H Lomeli; J Mosbacher; T Melcher; T Höger; J R Geiger; T Kuner; H Monyer; M Higuchi; A Bach; P H Seeburg
Journal:  Science       Date:  1994-12-09       Impact factor: 47.728

8.  Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase.

Authors:  S Maas; T Melcher; A Herb; P H Seeburg; W Keller; S Krause; M Higuchi; M A O'Connell
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

9.  Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing.

Authors:  U Kim; Y Wang; T Sanford; Y Zeng; K Nishikura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

10.  A mammalian RNA editing enzyme.

Authors:  T Melcher; S Maas; A Herb; R Sprengel; P H Seeburg; M Higuchi
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

View more
  59 in total

1.  Prolonged α-amanitin treatment of cells for studying mutated polymerases causes degradation of DSIF160 and other proteins.

Authors:  David C Tsao; Noh Jin Park; Anita Nag; Harold G Martinson
Journal:  RNA       Date:  2011-12-22       Impact factor: 4.942

2.  Transcriptional priming of cytoplasmic post-transcriptional regulation.

Authors:  Itay Tirosh
Journal:  Transcription       Date:  2011-11-01

3.  Accurate identification of A-to-I RNA editing in human by transcriptome sequencing.

Authors:  Jae Hoon Bahn; Jae-Hyung Lee; Gang Li; Christopher Greer; Guangdun Peng; Xinshu Xiao
Journal:  Genome Res       Date:  2011-09-29       Impact factor: 9.043

Review 4.  Non-coding RNAs in the nervous system.

Authors:  Mark F Mehler; John S Mattick
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

5.  An editor controlled by transcription.

Authors:  Eva M Riedmann; Michael F Jantsch
Journal:  EMBO Rep       Date:  2006-03       Impact factor: 8.807

6.  The C-terminal domain of RNA Pol II helps ensure that editing precedes splicing of the GluR-B transcript.

Authors:  Kicki Ryman; Nova Fong; Eva Bratt; David L Bentley; Marie Ohman
Journal:  RNA       Date:  2007-05-24       Impact factor: 4.942

7.  Functional coupling of last-intron splicing and 3'-end processing to transcription in vitro: the poly(A) signal couples to splicing before committing to cleavage.

Authors:  Frank Rigo; Harold G Martinson
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

8.  Genome-wide analysis of A-to-I RNA editing by single-molecule sequencing in Drosophila.

Authors:  Georges St Laurent; Michael R Tackett; Sergey Nechkin; Dmitry Shtokalo; Denis Antonets; Yiannis A Savva; Rachel Maloney; Philipp Kapranov; Charles E Lawrence; Robert A Reenan
Journal:  Nat Struct Mol Biol       Date:  2013-09-29       Impact factor: 15.369

9.  A-to-I RNA editing alters less-conserved residues of highly conserved coding regions: implications for dual functions in evolution.

Authors:  Yun Yang; Jianning Lv; Bin Gui; Heng Yin; Xiaojie Wu; Yaozhou Zhang; Yongfeng Jin
Journal:  RNA       Date:  2008-06-20       Impact factor: 4.942

Review 10.  A role for A-to-I RNA editing in temperature adaptation.

Authors:  Sandra C Garrett; Joshua J C Rosenthal
Journal:  Physiology (Bethesda)       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.